STAT Webinar: Gene editing, CRISPR, and what comes next
This is the year when CRISPR will move out of the lab and into patients in the first U.S. clinical trials of the genome-editing technology. What might success look like?
Join STAT senior science writer Sharon Begley and national biotech columnist Adam Feuerstein for a free STAT webinar, as they tell you what CRISPR is (and is not), what other genome-editing methods are already being tested, and which companies are betting on these technologies to one day treat, cure, or prevent disease.
Contact: Casey Bleho
Contact Phone: (617) 929-2830
Contact Email: email@example.com